Apellis Pharmaceuticals Aktie
15,22
EUR
+0,18
EUR
+1,18
%
16,94
USD
-0,47
USD
-2,67
%
Werbung
Apellis Pharmaceuticals Aktie Analyse
01.08.19 | Apellis Pharmaceuticals Overweight | Cantor Fitzgerald | |
30.07.18 | Apellis Pharmaceuticals Buy | B. Riley FBR | |
24.05.18 | Apellis Pharmaceuticals Overweight | Cantor Fitzgerald | |
12.04.18 | Apellis Pharmaceuticals Neutral | B. Riley FBR, Inc. | |
08.02.18 | Apellis Pharmaceuticals Buy | B. Riley FBR, Inc. |
Werbung
Werbung